These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 6625894)
1. [Antibody-dependent cell-mediated cytotoxicity (K-cell population) of peripheral lymphocytes in Kawasaki disease and allergic conditions. 1. Relation between K-cell population and the blood immune complex content in Kawasaki disease]. Suzuki M Arerugi; 1983 Mar; 32(3):164-72. PubMed ID: 6625894 [No Abstract] [Full Text] [Related]
2. Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease). Lin CY; Hwang B Ann Allergy; 1987 Oct; 59(4):291-7. PubMed ID: 3662131 [TBL] [Abstract][Full Text] [Related]
3. [Antibody-dependent cell-mediated cytotoxicity (K-cell population) in Kawasaki disease and allergic disease. Part 2. The K-cell population in bronchial asthma and atopic dermatitis]. Suzuki M Arerugi; 1984 Apr; 33(4):216-23. PubMed ID: 6477134 [No Abstract] [Full Text] [Related]
4. [A study of immune complexes in Kawasaki disease]. Yanase Y; Kawasaki T; Yoshinoya S; Aikawa T; Hashimoto Y; Mitamura T; Miyoshi Y; Muranaka M; Miyamoto T Arerugi; 1984 Jan; 33(1):59-65. PubMed ID: 6743029 [No Abstract] [Full Text] [Related]
5. Immune complexes in Kawasaki syndrome: a review. Pachman LM; Herold BC; Davis AT; Hang LM; Schaller JG; Beckwith B; Arroyave CM; Gawryl MS; Lint T; Shulman ST Prog Clin Biol Res; 1987; 250():193-207. PubMed ID: 3321076 [No Abstract] [Full Text] [Related]
6. Immune complex study of biopsy specimens from Kawasaki disease patients. Fujimoto T; Kato H; Inoue O; Tomita S; Koga Y Prog Clin Biol Res; 1987; 250():209-17. PubMed ID: 3321077 [No Abstract] [Full Text] [Related]
7. [IgG subclasses in the serum and circulating immune complexes in patients with Kawasaki disease]. Li CR Zhonghua Yi Xue Za Zhi; 1989 Oct; 69(10):578-81, 40. PubMed ID: 2620267 [TBL] [Abstract][Full Text] [Related]
8. Kawasaki disease: circulating immune complexes monitored during the disease. Salo E; Pelkonen P; Kekomaki R; Ruuskanen O; Viander M; Wager O Prog Clin Biol Res; 1987; 250():563. PubMed ID: 3423075 [No Abstract] [Full Text] [Related]
12. [Study on peripheral blood mononuclear cell subpopulations in children. Part II. Peripheral blood mononuclear cell subpopulations in patients with Kawasaki disease]. Ogiwara A Arerugi; 1984 Jul; 33(7):369-75. PubMed ID: 6497666 [No Abstract] [Full Text] [Related]
13. [Current viewpoints in the pathogenesis of Kawasaki disease]. Bollen CW; Rijkers GT; Zegers BJ; de Graeff-Meeder ER Ned Tijdschr Geneeskd; 1995 Mar; 139(11):549-54. PubMed ID: 7700390 [No Abstract] [Full Text] [Related]
14. [Studies of immunotherapy of malignant urogenital tumors: 2nd report. Changes in the K-cell population of the peripheral blood in patients with malignant tumors and the significance of antibody dependent cell-mediated cytotoxicity (ADCC) in OK-432 immunotherapy]. Fujioka T; Tanji S; Koike H; Suzuki K; Aoki H; Banya Y; Kubo T; Ohhori T Nihon Hinyokika Gakkai Zasshi; 1987 Jan; 78(1):29-38. PubMed ID: 3599595 [No Abstract] [Full Text] [Related]